Lexicon, BridgeBio, Esperion, Pfizer, More Celebrate Wins at 71st ACC MeetingAstraZeneca, BioSpace, Cholesterol, Clinical Data, Clinical Trial Endpoints, Elevated Low-Density Lipoprotein Cholesterol (LDL-C), Heart Attacks, Heart Failure with Reduced Ejection Fraction (HFrEF), Pfizer, Primary Endpoints, R&D, Regeneron Pharmaceuticals, Sanofi, Small-Interfering RNA (siRNA) Class, Strokes, TTR Amyloidosis (ATTR)The 71st annual American College of Cardiology’s Scientific Session saw several wins – and some “mehs” led by some of biopharma’s largest companies, according to BioSpace. Read more April 4, 2022/by BioSpace https://www.pharmalive.com/wp-content/uploads/2022/04/Lexicon-BridgeBio-Esperion-Pfizer-More-Celebrate-Wins-at-71st-ACC-Meeting-BioSpace-4-4-22.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2022-04-04 13:17:242022-04-05 10:30:04Lexicon, BridgeBio, Esperion, Pfizer, More Celebrate Wins at 71st ACC Meeting